Crestor (Rosuvastatin) News and Research

RSS
Crestor (Rosuvastatin) is a once-daily prescription medication for use as an adjunct to diet in the treatment of various lipid disorders including primary hypercholesterolemia, mixed dyslipidemia and isolated hypertriglyceridemia. It is a member of the statin (HMG-CoA reductase inhibitors) class of drug therapy.
Crestor (rosuvastatin calcium) shown to significantly reduce major cardiovascular events

Crestor (rosuvastatin calcium) shown to significantly reduce major cardiovascular events

Metabolic genes tied to inflammatory predictor of heart disease and stroke risk

Metabolic genes tied to inflammatory predictor of heart disease and stroke risk

Genomas awarded $1.2 million to develop DNA-guided system for management of statin therapy

Genomas awarded $1.2 million to develop DNA-guided system for management of statin therapy

Abbott and AstraZeneca confirm Phase III clinical trials of Fenofibrate ABT-335 and Crestor as fixed-dose combination

Abbott and AstraZeneca confirm Phase III clinical trials of Fenofibrate ABT-335 and Crestor as fixed-dose combination

Coated aspirin doesn't guarantee problem-free use

Coated aspirin doesn't guarantee problem-free use

Statins show extra benefit in raising "good" HDL cholesterol levels

Statins show extra benefit in raising "good" HDL cholesterol levels

Statins slow the progression of aortic valve stenosis

Statins slow the progression of aortic valve stenosis

More physicians now visit web sites to find information on brand-name prescription drugs

More physicians now visit web sites to find information on brand-name prescription drugs

Statin drug reverses heart disease

Statin drug reverses heart disease

Intensive cholesterol lowering with a statins can partially reverse the buildup of plaque in the coronary arteries

Intensive cholesterol lowering with a statins can partially reverse the buildup of plaque in the coronary arteries

Statins cut the risk of serious infection

Statins cut the risk of serious infection

Statins account for 81% of first-line therapies for dyslipidemia treatment

Statins account for 81% of first-line therapies for dyslipidemia treatment

Drug company proposes FDA check all drug advertising prior to marketing

Drug company proposes FDA check all drug advertising prior to marketing

Most serious side effects in statins may be higher in one of the newest drugs, rosuvastatin (Crestor)

Most serious side effects in statins may be higher in one of the newest drugs, rosuvastatin (Crestor)

New cholesterol drug Crestor causes safety concerns

New cholesterol drug Crestor causes safety concerns

New statin study shows arrested progression of atherosclerosis

New statin study shows arrested progression of atherosclerosis

FDA issues information on the risks and benefits of Crestor

FDA issues information on the risks and benefits of Crestor

AstraZeneca reconfirms the safety of Crestor

AstraZeneca reconfirms the safety of Crestor

FDA Vioxx fiasco raises questions about AIDS drug approvals for developing world

FDA Vioxx fiasco raises questions about AIDS drug approvals for developing world

Cholesterol-lowering drugs can interact with grapefruit juice and increase the risk of the drugs' potential side-effects

Cholesterol-lowering drugs can interact with grapefruit juice and increase the risk of the drugs' potential side-effects